|
1.
|
Shi Y: Mechanisms of caspase activation
and inhibition during apoptosis. Mol Cell. 9:459–470. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Raff M: Cell suicide for beginners.
Nature. 396:119–122. 1998. View
Article : Google Scholar : PubMed/NCBI
|
|
3.
|
Thompson CB: Apoptosis in the pathogenesis
and treatment of disease. Science. 267:1456–1462. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
4.
|
Hengartner MO: The biochemistry of
apoptosis. Nature. 407:770–776. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
5.
|
Li H, Zhu H, Xu CJ and Yuan J: Cleavage of
BID by caspase 8 mediates the mitochondrial damage in the Fas
pathway of apoptosis. Cell. 94:491–501. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Varfolomeev EE, Schuchmann M, Luria V, et
al: Targeted disruption of the mouse Caspase 8 gene ablates cell
death induction by the TNF receptors, Fas/Apo1, and DR3 and is
lethal prenatally. Immunity. 9:267–276. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Kang TB, Ben-Moshe T, Varfolomeev EE, et
al: Caspase-8 serves both apoptotic and nonapoptotic roles. J
Immunol. 173:2976–2984. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Kang TB, Oh GS, Scandella E, et al:
Mutation of a self-processing site in caspase-8 compromises its
apoptotic but not its nonapoptotic functions in bacterial
artificial chromosometransgenic mice. J Immunol. 181:2522–2532.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Sakamaki K, Inoue T, Asano M, et al: Ex
vivo whole-embryo culture of caspase-8-deficient embryos normalize
their aberrant phenotypes in the developing neural tube and heart.
Cell Death Differ. 9:1196–1206. 2002. View Article : Google Scholar
|
|
10.
|
Galluzzi L, Kepp O and Kroemer G: RIP
kinases initiate programmed necrosis. J Mol Cell Biol. 1:8–10.
2009. View Article : Google Scholar
|
|
11.
|
Boldin MP, Goncharov TM, Goltsev YV and
Wallach D: Involvement of MACH, a novel MORT1/FADD-interacting
protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell.
85:803–815. 1996. View Article : Google Scholar
|
|
12.
|
Scaffidi C, Medema JP, Krammer PH and
Peter ME: FLICE is predominantly expressed as two functionally
active isoforms, caspase-8/a and caspase-8/b. J Biol Chem.
272:26953–26958. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Horiuchi T, Himeji D, Tsukamoto H,
Harashima S, Hashimura C and Hayashi K: Dominant expression of a
novel splice variant of caspase-8 in human peripheral blood
lymphocytes. Biochem Biophys Res Commun. 272:877–881. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Himeji D, Horiuchi T, Tsukamoto H, Hayashi
K, Watanabe T and Harada M: Characterization of caspase-8L: a novel
isoform of caspase-8 that behaves as an inhibitor of the caspase
cascade. Blood. 99:4070–4078. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Miller MA, Karacay B, Zhu X, O’Dorisio MS
and Sandler AD: Caspase 8L, a novel inhibitory isoform of caspase
8, is associated with undifferentiated neuroblastoma. Apoptosis.
11:15–24. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Mohr A, Zwacka RM, Jarmy G, et al:
Caspase-8L expression protects CD34+hematopoietic
progenitor cells and leukemic cells from CD95-mediated apoptosis.
Oncogene. 24:2421–2429. 2005.PubMed/NCBI
|
|
17.
|
Casciano I, De Ambrosis A, Croce M, et al:
Expression of the caspase-8 gene in neuroblastoma cells is
regulated through an essential interferon-sensitive response
element (ISRE). Cell Death Differ. 11:131–134. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Casciano I, Banelli B, Croce M, et al:
Caspase-8 gene expression in neuroblastoma. Ann NY Acad Sci.
1028:157–167. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Teitz T, Wei T, Valentine MB, et al:
Caspase 8 is deleted or silenced preferentially in childhood
neuroblastomas with amplification of MYCN. Nat Med. 6:529–535.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Kim HS, Lee JW, Soung YH, et al:
Inactivating mutations of caspase-8 gene in colorectal carcinomas.
Gastroenterology. 125:708–715. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Mandruzzato S, Brasseur F, Andry G, Boon T
and van der Bruggen P: A CASP-8 mutation recognized by cytolytic T
lymphocytes on a human head and neck carcinoma. J Exp Med.
186:785–793. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Soung YH, Lee JW, Kim SY, et al: CASPASE-8
gene is inactivated by somatic mutations in gastric carcinomas.
Cancer Res. 65:815–821. 2005.PubMed/NCBI
|
|
23.
|
Takita J, Yang HW, Chen YY, et al: Allelic
imbalance on chromosome 2q and alterations of the caspase 8 gene in
neuroblastoma. Oncogene. 20:4424–4432. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Hopkins-Donaldson S, Ziegler A, Kurtz S,
et al: Silencing of death receptor and caspase-8 expression in
small cell lung carcinoma cell lines and tumors by DNA methylation.
Cell Death Differ. 10:356–364. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Abnet CC, Wang Z, Song X, et al: Genotypic
variants at 2q33 and risk of esophageal squamous cell carcinoma in
China: a meta-analysis of genome-wide association studies. Hum Mol
Genet. 21:2132–2141. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Maher B: ENCODE: The human encyclopaedia.
Nature. 489:46–48. 2012. View Article : Google Scholar
|
|
27.
|
Vaillant I and Paszkowski J: Role of
histone and DNA methylation in gene regulation. Curr Opin Plant
Biol. 10:528–533. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Darbinian N, White MK, Gallia GL, Amini S,
Rappaport J and Khalili K: Interaction between the pura and E2F-1
transcription factors. Anticancer Res. 24:2585–2594.
2004.PubMed/NCBI
|
|
29.
|
Kadonaga JT: Regulation of RNA polymerase
II transcription by sequence-specific DNA binding factors. Cell.
116:247–257. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
30.
|
Oei SL, Griesenbeck J, Schweiger M and
Ziegler M: Regulation of RNA polymerase II-dependent transcription
by poly(ADP-ribosyl)ation of transcription factors. J Biol Chem.
273:31644–31647. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
31.
|
Coulon A, Chow CC, Singer RH and Larson
DR: Eukaryotic transcriptional dynamics: from single molecules to
cell populations. Nat Rev Genet. 14:572–584. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32.
|
Lenhard B, Sandelin A and Carninci P:
Metazoan promoters: emerging characteristics and insights into
transcriptional regulation. Nat Rev Genet. 13:233–245.
2012.PubMed/NCBI
|
|
33.
|
Kornblihtt AR, Schor IE, Allo M, Dujardin
G, Petrillo E and Munoz MJ: Alternative splicing: a pivotal step
between eukaryotic transcription and translation. Nat Rev Mol Cell
Biol. 14:153–165. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34.
|
Ayoubi TA and Van De Ven WJ: Regulation of
gene expression by alternative promoters. FASEB J. 10:453–460.
1996.PubMed/NCBI
|
|
35.
|
Landry JR, Mager DL and Wilhelm BT:
Complex controls: the role of alternative promoters in mammalian
genomes. Trends Genet. 19:640–648. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36.
|
Carninci P, Kasukawa T, Katayama S, et al:
The transcriptional landscape of the mammalian genome. Science.
309:1559–1563. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
37.
|
Katayama S, Tomaru Y, Kasukawa T, et al:
Antisense transcription in the mammalian transcriptome. Science.
309:1564–1566. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38.
|
Carninci P, Sandelin A, Lenhard B, et al:
Genome-wide analysis of mammalian promoter architecture and
evolution. Nat Genet. 38:626–635. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39.
|
Yoo EJ, Cooke NE and Liebhaber SA:
Identification of a secondary promoter within the human B cell
receptor component gene hCD79b. J Biol Chem. 288:18353–18365. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
40.
|
Laszkiewicz A, Cebrat M, Miazek A and
Kisielow P: Complexity of transcriptional regulation within the Rag
locus: identification of a second Nwc promoter region within the
Rag2 intron. Immunogenetics. 63:183–187. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
41.
|
Pinte S, Guerardel C, Deltour-Balerdi S,
Godwin AK and Leprince D: Identification of a second G-C-rich
promoter conserved in the human, murine and rat tumor suppressor
genes HIC1. Oncogene. 23:4023–4031. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
42.
|
Rini D and Calabi F: Identification and
comparative analysis of a second runx3 promoter. Gene. 273:13–22.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
43.
|
Burton EA, Tinsley JM, Holzfeind PJ,
Rodrigues NR and Davies KE: A second promoter provides an
alternative target for therapeutic up-regulation of utrophin in
Duchenne muscular dystrophy. Proc Natl Acad Sci USA.
96:14025–14030. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
44.
|
Sun T, Gao Y, Tan W, et al: A
six-nucleotide insertion-deletion polymorphism in the CASP8
promoter is associated with susceptibility to multiple cancers. Nat
Genet. 39:605–613. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
45.
|
Haiman CA, Garcia RR, Kolonel LN,
Henderson BE, Wu AH and Le Marchand L: A promoter polymorphism in
the CASP8 gene is not associated with cancer risk. Nat Genet.
40:259–260. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46.
|
Frank B, Rigas SH, Bermejo JL, et al: The
CASP8 -652 6N del promoter polymorphism and breast cancer risk: a
multicenter study. Breast Cancer Res Treat. 111:139–144. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
47.
|
Cybulski C, Wokolorczyk D, Gliniewicz B,
et al: A six-nucleotide deletion in the CASP8 promoter is not
associated with a susceptibility to breast and prostate cancers in
the Polish population. Breast Cancer Res Treat. 112:367–368. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
48.
|
Pittman AM, Broderick P, Sullivan K, et
al: CASP8 variants D302H and -652 6N ins/del do not influence the
risk of colorectal cancer in the United Kingdom population. Br J
Cancer. 98:1434–1436. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
49.
|
Xiao MS, Chang L, Li WL, et al: Genetic
polymorphisms of the CASP8 gene promoter may not be associated with
colorectal cancer in Han Chinese from Southwest China. PLoS One.
8:e675772013. View Article : Google Scholar : PubMed/NCBI
|
|
50.
|
de Martino M, Haitel A, Schatzl G,
Klingler HC and Klatte T: The CASP8 -652 6N insertion/deletion
promoter polymorphism is associated with renal cell carcinoma risk
and metastasis. J Urol. 190:717–722. 2013.PubMed/NCBI
|
|
51.
|
Malik MA, Zargar SA and Mittal B: A
six-nucleotide deletion polymorphism in the casp8 promoter is
associated with reduced risk of esophageal and gastric cancers in
Kashmir valley. Indian J Hum Genet. 17:152–156. 2011. View Article : Google Scholar
|
|
52.
|
Li C, Lu J, Liu Z, et al: The
six-nucleotide deletion/insertion variant in the CASP8 promoter
region is inversely associated with risk of squamous cell carcinoma
of the head and neck. Cancer Prev Res. 3:246–253. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
53.
|
Wang M and Zhang Z, Tian Y, Shao J and
Zhang Z: A six-nucleotide insertion-deletion polymorphism in the
CASP8 promoter associated with risk and progression of bladder
cancer. Clin Cancer Res. 15:2567–2572. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
54.
|
Ni C, Ye Y, Wang M, et al: A
six-nucleotide insertion-deletion polymorphism in the CASP8
promoter is associated with risk of coal workers’ pneumoconiosis. J
Toxicol Environ Health A. 72:712–716. 2009.PubMed/NCBI
|
|
55.
|
Qu H and Fang X: A brief review on the
Human Encyclopedia of DNA Elements (ENCODE) project. Genomics
Proteomics Bioinformatics. 11:135–141. 2013. View Article : Google Scholar
|
|
56.
|
Gerstein MB, Kundaje A, Hariharan M, et
al: Architecture of the human regulatory network derived from
ENCODE data. Nature. 489:91–100. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
57.
|
Bajic VB, Brent MR, Brown RH, et al:
Performance assessment of promoter predictions on ENCODE regions in
the EGASP experiment. Genome Biol. 7(Suppl 1): S31–13. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
58.
|
Bardet AF, Steinmann J, Bafna S, Knoblich
JA, Zeitlinger J and Stark A: Identification of transcription
factor binding sites from ChIP-seq data at high resolution.
Bioinformatics. 29:2705–2713. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
59.
|
Johnson EM: The Pur protein family: clues
to function from recent studies on cancer and AIDS. Anticancer Res.
23:2093–2100. 2003.PubMed/NCBI
|
|
60.
|
Johnson EM, Daniel DC and Gordon J: The
pur protein family: genetic and structural features in development
and disease. J Cell Physiol. 228:930–937. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
61.
|
Darbinian N, Gallia GL and Khalili K:
Helix-destabilizing properties of the human single-stranded DNA-
and RNA-binding protein Puralpha. J Cell Biochem. 80:589–595. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
62.
|
Algeciras-Schimnich A, Barnhart BC and
Peter ME: Apoptosis-independent functions of killer caspases. Curr
Opin Cell Biol. 14:721–726. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
63.
|
Launay S, Hermine O, Fontenay M, Kroemer
G, Solary E and Garrido C: Vital functions for lethal caspases.
Oncogene. 24:5137–5148. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
64.
|
Knudsen S: Promoter2.0: for the
recognition of PolII promoter sequences. Bioinformatics.
15:356–361. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
65.
|
Reese MG: Application of a time-delay
neural network to promoter annotation in the Drosophila
melanogaster genome. Comput Chem. 26:51–56. 2001. View Article : Google Scholar
|
|
66.
|
Solovyev V and Salamov A: The Gene-Finder
computer tools for analysis of human and model organisms genome
sequences. Proc Int Conf Intell Syst Mol Biol. 5:294–302.
1997.PubMed/NCBI
|
